$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000144530513001699 Filed on July 25, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$1.606B	$1.479B
YoY Change	8.56%	26.74%
Cost Of Revenue	$1.334B	$1.348B
YoY Change	-1.05%	36.37%
Gross Profit	$271.8M	$131.0M
YoY Change	107.48%	-26.61%
Gross Profit Margin	16.93%	8.86%
Selling, General & Admin	$208.4M	$164.2M
YoY Change	26.92%	21.99%
% of Gross Profit	76.67%	125.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$22.11M	$19.67M
YoY Change	12.39%	19.22%
% of Gross Profit	8.13%	15.02%
Operating Expenses	$225.4M	$180.4M
YoY Change	24.94%	22.64%
Operating Profit	$46.45M	-$49.43M
YoY Change	-193.96%	-257.37%
Interest Expense	$11.67M	$3.808M
YoY Change	206.38%	-202.92%
% of Operating Profit	25.12%
Other Income/Expense, Net	-$15.17M	-$4.894M
YoY Change	209.95%
Pretax Income	$31.28M	-$54.32M
YoY Change	-157.57%	-295.92%
Income Tax	$15.48M	-$21.27M
% Of Pretax Income	49.5%
Net Earnings	$24.57M	-$37.31M
YoY Change	-165.86%	-313.91%
Net Earnings / Revenue	1.53%	-2.52%
Basic Earnings Per Share	$0.54	-$0.80
Diluted Earnings Per Share	$0.53	-$0.80
COMMON SHARES
Basic Shares Outstanding	45.45M shares	46.36M shares
Diluted Shares Outstanding	46.51M shares	46.36M shares

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.461B	$1.072B
YoY Change	36.31%	31.4%
Cash & Equivalents	$742.7M	$727.1M
Short-Term Investments	$718.5M	$344.9M
Other Short-Term Assets	$47.82M	$56.70M
YoY Change	-15.67%	43.18%
Inventory
Prepaid Expenses
Receivables	$213.8M	$161.0M
Other Receivables	$0.00	$31.40M
Total Short-Term Assets	$1.745B	$1.321B
YoY Change	32.08%	28.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$249.3M	$206.5M
YoY Change	20.73%	75.3%
Goodwill	$153.2M
YoY Change
Intangibles
YoY Change
Long-Term Investments	$12.50M	$13.10M
YoY Change	-4.58%	-31.05%
Other Assets	$35.77M	$135.4M
YoY Change	-73.58%	25.72%
Total Long-Term Assets	$835.1M	$596.5M
YoY Change	40.0%	4.25%
TOTAL ASSETS
Total Short-Term Assets	$1.745B	$1.321B
Total Long-Term Assets	$835.1M	$596.5M
Total Assets	$2.580B	$1.918B
YoY Change	34.55%	19.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$180.2M	$136.1M
YoY Change	32.4%	2.33%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$1.100M
YoY Change	-100.0%
Total Short-Term Liabilities	$707.2M	$839.1M
YoY Change	-15.72%	37.83%
LONG-TERM LIABILITIES
Long-Term Debt	$761.5M	$269.3M
YoY Change	182.77%	61.55%
Other Long-Term Liabilities	$23.94M	$22.30M
YoY Change	7.37%	-49.89%
Total Long-Term Liabilities	$23.94M	$291.6M
YoY Change	-91.79%	38.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$707.2M	$839.1M
Total Long-Term Liabilities	$23.94M	$291.6M
Total Liabilities	$1.704B	$1.172B
YoY Change	45.41%	40.37%
SHAREHOLDERS EQUITY
Retained Earnings	$554.7M
YoY Change
Common Stock	$324.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00
YoY Change
Treasury Stock Shares	0.000 shares
Shareholders Equity	$876.4M	$746.0M
YoY Change
Total Liabilities & Shareholders Equity	$2.580B	$1.918B
YoY Change	34.55%	19.81%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	$24.57M	-$37.31M
YoY Change	-165.86%	-313.91%
Depreciation, Depletion And Amortization	$22.11M	$19.67M
YoY Change	12.39%	19.22%
Cash From Operating Activities	-$131.8M	$185.4M
YoY Change	-171.09%	501.95%
INVESTING ACTIVITIES
Capital Expenditures	-$24.00M	-$19.80M
YoY Change	21.21%	23.75%
Acquisitions
YoY Change
Other Investing Activities	-$386.6M	$1.200M
YoY Change	-32316.67%	-105.19%
Cash From Investing Activities	-$410.6M	-$18.60M
YoY Change	2107.53%	-52.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$50.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	115.7M	42.60M
YoY Change	171.6%	1051.35%
NET CHANGE
Cash From Operating Activities	-131.8M	185.4M
Cash From Investing Activities	-410.6M	-18.60M
Cash From Financing Activities	115.7M	42.60M
Net Change In Cash	-426.7M	209.4M
YoY Change	-303.77%	-4753.33%
FREE CASH FLOW
Cash From Operating Activities	-$131.8M	$185.4M
Capital Expenditures	-$24.00M	-$19.80M
Free Cash Flow	-$107.8M	$205.2M
YoY Change	-152.53%	338.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9812000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2705000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	285524000	USD
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	324360000	USD
CY2013Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	79000000	USD
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	79000000	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	184034000	USD
CY2013Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	180227000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6520000	USD
CY2013Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	15496000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-457000	USD
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7729000	USD
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5146000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12150000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9688000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2915000	USD
CY2012Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1472000	USD
CY2013Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5965000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	515000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2366000	USD
CY2012Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	549700000	USD
CY2013Q2	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	607500000	USD
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	60000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	43000	shares
CY2013Q2	us-gaap	Assets Assets	2579916000	USD
CY2012Q4	us-gaap	Assets Assets	1934822000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	1349126000	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	1744802000	USD
CY2013Q2	us-gaap	Auction Rate Securities Noncurrent AuctionRateSecuritiesNoncurrent	12527000	USD
CY2012Q4	us-gaap	Auction Rate Securities Noncurrent AuctionRateSecuritiesNoncurrent	13419000	USD
CY2012Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	357000000	USD
CY2013Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	735434000	USD
CY2013Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	731071000	USD
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	356264000	USD
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	528426000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	89195000	USD
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	12527000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	13419000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	373250000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	369844000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	13400000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	12527000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	735434000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	348784000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	348700000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	731071000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	795770000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	742670000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	493827000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	727092000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-53100000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	233265000	USD
CY2013Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	53.8475
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46762000	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45683000	shares
CY2013Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2012Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	47000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	52238000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18597000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	22063000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36982000	USD
CY2013Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	585825000	USD
CY2012Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	175468000	USD
CY2013Q2	us-gaap	Costs And Expenses CostsAndExpenses	1559388000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	2809217000	USD
CY2012Q2	us-gaap	Costs And Expenses CostsAndExpenses	1528593000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	3081914000	USD
CY2013Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	51319000	USD
CY2012Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	58313000	USD
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2013Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	585825000	USD
CY2013Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	737000000	USD
CY2013Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2013-02-15
CY2013Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	151175000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	141798000	USD
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	45949000	USD
CY2013Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	21995000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	32443000	USD
CY2013Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3919000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	37900000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	33578000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31058000	USD
CY2013Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17015000	USD
CY2012Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16210000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38010000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	43907000	USD
CY2012Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19671000	USD
CY2013Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22108000	USD
CY2012Q4	us-gaap	Derivative Assets DerivativeAssets	0	USD
CY2013Q2	us-gaap	Derivative Assets DerivativeAssets	207123000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1086000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3384000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-1086000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-3384000	USD
CY2013Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	207017000	USD
CY2012Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1307000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	68987000	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	13419000	USD
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	16134000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3817000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	30942000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	77711000	USD
	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	500000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-10143000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-4214000	USD
CY2013Q2	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-9968000	USD
CY2012Q2	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-3268000	USD
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.80
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.19
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.80
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.17
CY2013Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	700000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M18D
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1544000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	3677000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	38000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	50000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	290000	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	1059000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	358000	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	1635000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	-75074000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-77747000	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	4350000	USD
CY2013Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	12633000	USD
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	1747000	USD
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	0	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	241048000	USD
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	125819000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	161479000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	302757000	USD
CY2013Q2	us-gaap	Goodwill Goodwill	153152000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	151088000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	3083045000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	2701196000	USD
CY2012Q2	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1432403000	USD
CY2013Q2	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1548612000	USD
CY2013Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	56935000	USD
CY2013Q2	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	4238000	USD
CY2013Q2	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	4241000	USD
CY2013Q2	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	52697000	USD
CY2013Q2	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	52694000	USD
CY2013Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	56935000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	15796000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-33057000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	46318000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-13163000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-54324000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-22310000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	86244000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	31277000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.35
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.71
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.29
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.01
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.71
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.34
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.29
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-6054000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	8168000	USD
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-4249000	USD
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	8775000	USD
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.19
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.13
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.09
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.18
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.17
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.09
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.19
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.13
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15481000	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-21267000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9147000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39926000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	41407000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1074000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-16968000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-22982000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-19737000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	8976000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	22155000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1264000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-95849000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	125426000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	-29043000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	123062000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	4383000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	8012000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10352000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	22856000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-6891000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	64094000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	12834000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	2154000	USD
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	306000	shares
CY2013Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	683000	shares
CY2012Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2012Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2013Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	378000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	488000	shares
CY2013Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1628000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	2738000	USD
CY2012Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1059000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	3144000	USD
CY2012Q2	us-gaap	Interest Expense InterestExpense	3808000	USD
	us-gaap	Interest Expense InterestExpense	8106000	USD
CY2013Q2	us-gaap	Interest Expense InterestExpense	11667000	USD
	us-gaap	Interest Expense InterestExpense	24704000	USD
CY2013Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	9265000	USD
CY2012Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3225000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	6421000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	15515000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3506000	USD
CY2013Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3300000	USD
CY2012Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1753000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	5827000	USD
	us-gaap	Interest Paid InterestPaid	4719000	USD
	us-gaap	Interest Paid InterestPaid	21933000	USD
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-4298000	USD
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-3615000	USD
CY2012Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	10300000	USD
CY2013Q2	us-gaap	Liabilities Liabilities	1703529000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	1152508000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2579916000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1934822000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	23527000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	828037000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	707159000	USD
CY2012Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	494530000	USD
CY2013Q2	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	465487000	USD
CY2012Q4	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	40000000	USD
CY2013Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	170000000	USD
CY2013Q2	us-gaap	Long Term Debt LongTermDebt	737000000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1155000	USD
CY2013Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	550000000	USD
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	187000000	USD
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2013Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	342845000	USD
CY2013Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	718544000	USD
CY2013Q2	us-gaap	Minimum Lease Payments Sale Leaseback Transactions MinimumLeasePaymentsSaleLeasebackTransactions	476995000	USD
CY2013Q2	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Remainder Of Fiscal Year MinimumLeasePaymentsSaleLeasebackTransactionsRemainderOfFiscalYear	6600000	USD
CY2013Q2	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Thereafter MinimumLeasePaymentsSaleLeasebackTransactionsThereafter	385813000	USD
CY2013Q2	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Five Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinFiveYears	20137000	USD
CY2013Q2	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Four Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinFourYears	19496000	USD
CY2013Q2	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within One Year MinimumLeasePaymentsSaleLeasebackTransactionsWithinOneYear	14395000	USD
CY2013Q2	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Three Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinThreeYears	18877000	USD
CY2013Q2	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Two Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinTwoYears	18277000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	58589000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	490460000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-431812000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61307000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-111748000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	235983000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	24571000	USD
	us-gaap	Net Income Loss NetIncomeLoss	54486000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19217000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-37306000	USD
CY2013Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
	us-gaap	Operating Income Loss OperatingIncomeLoss	114319000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-49430000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	46446000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13118000	USD
CY2012Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	3977000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	10616000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	8236000	USD
CY2013Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5922000	USD
CY2013Q2	us-gaap	Other Assets Current OtherAssetsCurrent	47817000	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	28386000	USD
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35773000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19621000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	324000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2508000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2248000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	620000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-3626000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	523000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-4045000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1001000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	381000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-1537000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-1378000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	199000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23480000	USD
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23943000	USD
CY2013Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	0	USD
CY2012Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	86316000	USD
CY2013Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3502000	USD
CY2012Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1086000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3371000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1086000	USD
CY2012Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4894000	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15169000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-28075000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9192000	USD
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	149331000	USD
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000000	USD
CY2013Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000000	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	33301000	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	35229000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	144348000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	532151000	USD
	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	-6994000	USD
	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	23055000	USD
CY2012Q2	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	1317597000	USD
CY2013Q2	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	1294706000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	2395464000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	2582621000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	9162000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	0	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	10000000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	40000000	USD
CY2012Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	46900000	USD
CY2013Q2	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	527800000	USD
CY2012Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	44101000	USD
CY2013Q2	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	56935000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	500200000	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	554686000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	537973000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	5485000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	4852000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	75074000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	60000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	149300000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	136772000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	149420000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	221443000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	249298000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	142000	USD
CY2013Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	48000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	238000	USD
CY2012Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	174000	USD
CY2012Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	149682000	USD
CY2013Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	213776000	USD
CY2013Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	40000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	47471000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	573000	USD
	us-gaap	Revenues Revenues	3196233000	USD
CY2012Q2	us-gaap	Revenues Revenues	1479163000	USD
	us-gaap	Revenues Revenues	2796099000	USD
CY2013Q2	us-gaap	Revenues Revenues	1605834000	USD
	us-gaap	Sale Leaseback Transaction Gross Proceeds SaleLeasebackTransactionGrossProceeds	158694000	USD
	us-gaap	Sale Leaseback Transaction Gross Proceeds SaleLeasebackTransactionGrossProceeds	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9812000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	12150000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	21751	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	26.63
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1038880	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	31.53
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	986577	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1508485	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	23.74
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	29.10
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	495221	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	23.64
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	349261000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	300000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	45000000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	33.02
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5255000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	414061000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	404261000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	5255000	USD
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	404261000	shares
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	5045000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y9M18D
CY2012Q4	us-gaap	Shares Outstanding SharesOutstanding	46762000	shares
CY2011Q4	us-gaap	Shares Outstanding SharesOutstanding	45815000	shares
CY2012Q1	us-gaap	Shares Outstanding SharesOutstanding	46347000	shares
CY2013Q1	us-gaap	Shares Outstanding SharesOutstanding	45415000	shares
CY2013Q2	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	8600000	USD
CY2013Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	627700000	USD
CY2013Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	363200000	USD
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	546000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	54500000	shares
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11300000	USD
CY2013Q1	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	75000000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	5669000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	9390000	USD
CY2013Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1624959	shares
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	782314000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	876387000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	94100000	USD
	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	0.0375	USD
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	1747000	USD
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	79075000	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	61107000	USD
CY2013Q2	us-gaap	Technology Services Costs TechnologyServicesCosts	39305000	USD
CY2012Q2	us-gaap	Technology Services Costs TechnologyServicesCosts	30613000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	99428000	USD
CY2012Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	41724000	USD
CY2013Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	49672000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	83929000	USD
CY2013Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	111000	shares
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3000000	USD
CY2013Q2	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	50000000	USD
CY2013Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10600000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10600000	USD
CY2013Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	75000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	56000	USD
CY2013Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7400000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7200000	USD
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46355000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46507000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46176000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46506000	shares
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0	shares
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1248000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	8000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	198000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	31000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	361000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45712000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46176000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46355000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45446000	shares
CY2013Q2	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	17297000	USD
CY2012Q2	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	17486000	USD
	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	26250000	USD
	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	32193000	USD
CY2013Q2	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	3849000	USD
CY2012Q2	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	876000	USD
	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	10561000	USD
	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	1870000	USD
CY2012Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	300000	USD
CY2013Q2	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	7100000	USD
CY2013Q2	moh	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInInvestments	873000	USD
CY2012Q4	moh	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInInvestments	1231000	USD
CY2013Q2	moh	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInInvestments	3831000	USD
CY2012Q4	moh	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInInvestments	314000	USD
CY2012Q4	moh	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	809000	USD
CY2013Q2	moh	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	341000	USD
CY2012	moh	Current Year Payments For Medical Care Costs CurrentYearPaymentsForMedicalCareCosts	4649363000	USD
	moh	Current Year Payments For Medical Care Costs CurrentYearPaymentsForMedicalCareCosts	2206474000	USD
	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	46176000	shares
	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	45712000	shares
CY2012Q2	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	46355000	shares
CY2013Q2	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	45446000	shares
CY2012Q2	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46355000	shares
	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46506000	shares
CY2013Q2	moh	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	4704000	USD
CY2012Q4	moh	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	1545000	USD
CY2013Q2	moh	Available For Sale Securities In Unrealized Loss Position Less Than Twelve Months Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionLessThanTwelveMonthsQualitativeDisclosureNumberOfPositions	321	Security
CY2012Q4	moh	Available For Sale Securities In Unrealized Loss Position Less Than Twelve Months Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionLessThanTwelveMonthsQualitativeDisclosureNumberOfPositions	72	Security
CY2013Q2	moh	Available For Sale Securities In Unrealized Loss Position Twelve Months Or More Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionTwelveMonthsOrMoreQualitativeDisclosureNumberOfPositions	18	Security
CY2012Q4	moh	Available For Sale Securities In Unrealized Loss Position Twelve Months Or More Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionTwelveMonthsOrMoreQualitativeDisclosureNumberOfPositions	21	Security
CY2013Q2	moh	Benefit From Prior Period Claims Development BenefitFromPriorPeriodClaimsDevelopment	62800000	USD
CY2013Q2	moh	Call Spread Cash Paid CallSpreadCashPaid	74200000	USD
	moh	Class Of Warrant Or Right Trading Days Measurement Period ClassOfWarrantOrRightTradingDaysMeasurementPeriod	P160D
CY2013Q2	moh	Current Year Components Of Incurred Medical Care Costs CurrentYearComponentsOfIncurredMedicalCareCosts	1345592000	USD
CY2012	moh	Current Year Components Of Incurred Medical Care Costs CurrentYearComponentsOfIncurredMedicalCareCosts	5136055000	USD
	moh	Current Year Components Of Incurred Medical Care Costs CurrentYearComponentsOfIncurredMedicalCareCosts	2647083000	USD
CY2013Q2	moh	Current Year Payments For Medical Care Costs CurrentYearPaymentsForMedicalCareCosts	940186000	USD
	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46176000	shares
CY2013Q2	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46507000	shares
	moh	Derivative Losson Derivative Warrants DerivativeLossonDerivativeWarrants	3900000	USD
	moh	Derivative Settlement Amount DerivativeSettlementAmount	875000	USD
	moh	Derivative Settlement Amount DerivativeSettlementAmount	0	USD
CY2013Q2	moh	Derivative Settlement Amount DerivativeSettlementAmount	900000	USD
	moh	Discontinued Operation Tax Expense Benefitfrom Stock Abandon DiscontinuedOperationTaxExpenseBenefitfromStockAbandon	9500000	USD
CY2012Q4	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	228799000	USD
CY2013Q2	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	222139000	USD
CY2012Q4	moh	Health Plans Segment Receivables HealthPlansSegmentReceivables	127098000	USD
CY2013Q2	moh	Health Plans Segment Receivables HealthPlansSegmentReceivables	197296000	USD
CY2013Q2	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	175666000	USD
CY2012Q4	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	0	USD
CY2013Q2	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	465487000	USD
CY2013Q1	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	491145000	USD
CY2012Q4	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	494530000	USD
CY2011Q4	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	402476000	USD
CY2012Q2	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	21982000	USD
CY2013Q2	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	20496000	USD
	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	31381000	USD
	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	41111000	USD
	moh	Maximum Contract Term MaximumContractTerm	P4Y
	moh	Minimum Contract Term MinimumContractTerm	P3Y
	moh	Minimum Ebitda Percentage For Vesting Of Awards MinimumEbitdaPercentageForVestingOfAwards	0.025
	moh	Minimum Operating Revenue For Vesting Of Awards MinimumOperatingRevenueForVestingOfAwards	12000000000	USD
	moh	Number Of Categories For Component Of Premium Revenue NumberOfCategoriesForComponentOfPremiumRevenue	2	category
CY2013Q2	moh	Number Of Members Eligible For Health Care Programs NumberOfMembersEligibleForHealthCarePrograms	1800000	Customer
	moh	Number Of Operating Reportable Segments NumberOfOperatingReportableSegments	2	Segment
	moh	Numberof Renewal Options NumberofRenewalOptions	5	Option
	moh	Par Value Of Auction Rate Securities Sold ParValueOfAuctionRateSecuritiesSold	13400000	USD
CY2012	moh	Payments For Medical Care Costs PaymentsForMedicalCareCosts	5004706000	USD
CY2013Q2	moh	Payments For Medical Care Costs PaymentsForMedicalCareCosts	1321230000	USD
	moh	Payments For Medical Care Costs PaymentsForMedicalCareCosts	2613369000	USD
CY2012Q2	moh	Payments For Medical Services Fees To Related Party PaymentsForMedicalServicesFeesToRelatedParty	7000000	USD
CY2013Q2	moh	Payments For Medical Services Fees To Related Party PaymentsForMedicalServicesFeesToRelatedParty	8700000	USD
	moh	Payments For Medical Services Fees To Related Party PaymentsForMedicalServicesFeesToRelatedParty	13600000	USD
	moh	Payments For Medical Services Fees To Related Party PaymentsForMedicalServicesFeesToRelatedParty	16400000	USD
CY2011	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.098
CY2013Q1	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.102
CY2012	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.127
CY2011Q4	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.098
	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.012
CY2013Q2	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.010
CY2012	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.008
	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.010
CY2012	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.007
CY2013Q2	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.008
CY2012	moh	Policyholder Benefitsand Claims Incurred Net Health Continuingand Discontinued Operations PolicyholderBenefitsandClaimsIncurredNetHealthContinuingandDiscontinuedOperations	5096760000	USD
CY2013Q2	moh	Policyholder Benefitsand Claims Incurred Net Health Continuingand Discontinued Operations PolicyholderBenefitsandClaimsIncurredNetHealthContinuingandDiscontinuedOperations	1295572000	USD
	dei	Trading Symbol TradingSymbol	moh
	moh	Policyholder Benefitsand Claims Incurred Net Health Continuingand Discontinued Operations PolicyholderBenefitsandClaimsIncurredNetHealthContinuingandDiscontinuedOperations	2584326000	USD
CY2012Q2	moh	Premium Tax Expenses PremiumTaxExpenses	38354000	USD
	moh	Premium Tax Expenses PremiumTaxExpenses	80540000	USD
	moh	Premium Tax Expenses PremiumTaxExpenses	83883000	USD
CY2013Q2	moh	Premium Tax Expenses PremiumTaxExpenses	46883000	USD
CY2013Q2	moh	Prior Year Components Of Incurred Medical Care Costs PriorYearComponentsOfIncurredMedicalCareCosts	-50020000	USD
CY2012	moh	Prior Year Components Of Incurred Medical Care Costs PriorYearComponentsOfIncurredMedicalCareCosts	-39295000	USD
	moh	Prior Year Components Of Incurred Medical Care Costs PriorYearComponentsOfIncurredMedicalCareCosts	-36400000	USD
	moh	Prior Year Components Of Incurred Medical Care Costs PriorYearComponentsOfIncurredMedicalCareCosts	-62757000	USD
CY2012	moh	Prior Year Payments For Medical Care Costs PriorYearPaymentsForMedicalCareCosts	355343000	USD
CY2013Q2	moh	Prior Year Payments For Medical Care Costs PriorYearPaymentsForMedicalCareCosts	381044000	USD
	moh	Prior Year Payments For Medical Care Costs PriorYearPaymentsForMedicalCareCosts	406895000	USD
CY2012Q2	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	18362000	USD
CY2013Q2	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	21146000	USD
	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	42754000	USD
	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	28120000	USD
	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	0	USD
	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	53000000	USD
	moh	Sale Leaseback Transaction Termof Lease SaleLeasebackTransactionTermofLease	P25Y
	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue		USD
CY2012Q4	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValue	22.39
CY2012Q4	moh	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingIntrinsicValue		USD
CY2013Q2	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	22.74
	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue	17.93
	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue	17.63
	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue		USD
CY2013Q2	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValue	24.18
	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue	24.18
CY2013Q1	moh	Stock Repurchase Program Average Price Per Share StockRepurchaseProgramAveragePricePerShare	30.77
CY2013Q2	moh	Unrecognized Tax Benefits State Refund Claims UnrecognizedTaxBenefitsStateRefundClaims	8400000	USD
CY2012Q4	moh	Unrecognized Tax Benefits State Refund Claims UnrecognizedTaxBenefitsStateRefundClaims	8400000	USD
	moh	Unvested Share Based Compensation Recognition Period UnvestedShareBasedCompensationRecognitionPeriod	P2Y5M18D
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45684600	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer

Files In Submission

Name	View Source	Status
0001445305-13-001699-index-headers.html	Edgar Link	pending
0001445305-13-001699-index.html	Edgar Link	pending
0001445305-13-001699.txt	Edgar Link	pending
0001445305-13-001699-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
moh-20130630.xml	Edgar Link	completed
moh-20130630.xsd	Edgar Link	pending
moh-20130630x10q.htm	Edgar Link	pending
moh-20130630_cal.xml	Edgar Link	unprocessable
moh-20130630_def.xml	Edgar Link	unprocessable
moh-20130630_lab.xml	Edgar Link	unprocessable
moh-20130630_pre.xml	Edgar Link	unprocessable
moh-2013x06x30xex101.htm	Edgar Link	pending
moh-2013x06x30xex102.htm	Edgar Link	pending
moh-2013x06x30xex31.htm	Edgar Link	pending
moh-2013x06x30xex311.htm	Edgar Link	pending
moh-2013x06x30xex312.htm	Edgar Link	pending
moh-2013x06x30xex321.htm	Edgar Link	pending
moh-2013x06x30xex322.htm	Edgar Link	pending
moh20130630ex101image1.jpg	Edgar Link	pending
moh20130630ex101image2.gif	Edgar Link	pending
moh20130630ex101image5.gif	Edgar Link	pending
moh20130630ex102image1.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R48.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R49.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R50.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R51.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R52.xml	Edgar Link	unprocessable
R53.htm	Edgar Link	pending
R53.xml	Edgar Link	unprocessable
R54.htm	Edgar Link	pending
R54.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R55.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R56.xml	Edgar Link	unprocessable
R57.htm	Edgar Link	pending
R57.xml	Edgar Link	unprocessable
R58.htm	Edgar Link	pending
R58.xml	Edgar Link	unprocessable
R59.htm	Edgar Link	pending
R59.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R60.htm	Edgar Link	pending
R60.xml	Edgar Link	unprocessable
R61.htm	Edgar Link	pending
R61.xml	Edgar Link	unprocessable
R62.htm	Edgar Link	pending
R62.xml	Edgar Link	unprocessable
R63.htm	Edgar Link	pending
R63.xml	Edgar Link	unprocessable
R64.htm	Edgar Link	pending
R64.xml	Edgar Link	unprocessable
R65.htm	Edgar Link	pending
R65.xml	Edgar Link	unprocessable
R66.htm	Edgar Link	pending
R66.xml	Edgar Link	unprocessable
R67.htm	Edgar Link	pending
R67.xml	Edgar Link	unprocessable
R68.htm	Edgar Link	pending
R68.xml	Edgar Link	unprocessable
R69.htm	Edgar Link	pending
R69.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R70.htm	Edgar Link	pending
R70.xml	Edgar Link	unprocessable
R71.htm	Edgar Link	pending
R71.xml	Edgar Link	unprocessable
R72.htm	Edgar Link	pending
R72.xml	Edgar Link	unprocessable
R73.htm	Edgar Link	pending
R73.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2013 Q2 Form 10-Q Financial Statement

#000144530513001699 Filed on July 25, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2013 Q2 Form 10-Q Financial Statement

#000144530513001699 Filed on July 25, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh